IE
CORV

Israel Englander’s Correvio Pharma Corp. Ordinary Shares (Canada) CORV Stock Holding History

Israel Englander’s Portfolio CORV Stock Details CORV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-17,439
Closed -$34K – 4845
2019
Q3 		$34K Sell
17,439
-18,919
-52% -$38.3K ﹤0.01% 4070
2019
Q2 		$79K Buy
36,358
+8,561
+31% +$21.9K ﹤0.01% 3921
2019
Q1 		$88K Buy
+27,797
New +$89.9K ﹤0.01% 3857
2014
Q2 		– Sell
-77,422
Closed -$612K – 4071
2014
Q1 		$612K Buy
+77,422
New +$623K ﹤0.01% 2506

Other funds holding CORV

TA
Tamarack Advisers Carlsbad, California $2.12M AUM 58.09% 1-Year Est. Return
VF
Virtu Financial New York $3.18B AUM 65.92% 1-Year Est. Return
SR
Summer Road West Palm Beach, Florida $161M AUM 27.24% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
AIP
ARS Investment Partners New York $2.29B AUM 113.95% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
OAM
Oxford Asset Management Oxford, United Kingdom $203M AUM 34.78% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return

Israel Englander's CORV Position: Q4 2019 in Review

Israel Englander sold out of Correvio Pharma Corp. Ordinary Shares (Canada) (CORV) in Q4 2019, closing a stake of 17,439 shares — an estimated $34K sold.

Israel Englander first reported a position in CORV in Q1 2014 and held it in 4 quarters. The position peaked at $612K in Q1 2014. 31 funds tracked by Wall St. Rank hold CORV as of Q4 2019.

  • Israel Englander reported no remaining Correvio Pharma Corp. Ordinary Shares (Canada) position as of Q4 2019 after selling out during the quarter.
  • Israel Englander sold 17,439 Correvio Pharma Corp. Ordinary Shares (Canada) shares in Q4 2019, an estimated $34K.
  • Israel Englander first reported a position in Correvio Pharma Corp. Ordinary Shares (Canada) in Q1 2014 and held it in 4 quarters.
  • Israel Englander's Correvio Pharma Corp. Ordinary Shares (Canada) position peaked at $612K in Q1 2014.
  • 31 funds tracked by Wall St. Rank held Correvio Pharma Corp. Ordinary Shares (Canada) as of Q4 2019.

Based on Millennium Management's 13F filing for Q4 2019, filed 14 Feb 2020.